Home Compare BAYN.DE vs GSK.L
Stock Comparison · Industry comparison · Drug Manufacturers - General

Bayer Aktiengesellschaft vs GSK: Which Stock Looks Stronger in 2026?

GSK holds the cleaner structural position, with the lead spread across stability and growth. Bayer Aktiengesellschaft still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the STOXX 600 universe, making them directly comparable.

Updated 2026-05-17

The clearest separation starts in stability, but profitability adds another real layer to the result. GSK plc leads by 10 points on the overall comparison score.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. BAYN.DE and GSK.L share the same industry classification.

For a similarity-based comparison, see how Bayer Aktiengesellschaft and GSK each position within their functional peer groups in AssetNext.

Peer-Relative Score
BAYN.DE
Bayer Aktiengesellschaft
57
Peer-Score
Signal qualitylow
Peer basis: STOXX 600
vs
GSK.L
GSK plc
67
Peer-Score
Signal qualityMedium
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BAYN.DE vs GSK.L Profitability 36 68 Stability 24 76 Valuation 83 84 Growth 79 30 BAYN.DE GSK.L
Gap Ranking
#1 Stability +52
#2 Growth +49
#3 Profitability +32
#4 Valuation +1
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BAYN.DE and GSK.L Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BAYN.DEGSK.L Relative valuation Structural strength

The price setup looks more supportive for GSK plc, but Bayer Aktiengesellschaft still has the stronger structure.

Valuation position uses Forward P/E and peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
GSK plc ranks near the top of the group on stability; Bayer Aktiengesellschaft sits in the weaker half.
Growth
The same broad pattern appears on growth: Bayer Aktiengesellschaft ranks near the top of the group, while GSK plc stays in the weaker half.
Stability — Dominant Gap
BAYN.DE
24
GSK.L
76
Gap+52in favour of GSK.L

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

Earnings growth also leans toward BAYN.DE, which keeps the score lead from reading as a full growth sweep.

What this means for the comparison

Stability settles the comparison, while pricing and growth keep the broader setup from looking fully aligned.

Explore full peer positioning in AssetNext

Break down the BAYN.DE vs GSK.L comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BAYN.DE and GSK.L each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.